PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-121.56%
Both yoy net incomes decline, with CSIQ at -19.49%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-15.17%
Both reduce yoy D&A, with CSIQ at -100.00%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-121.56%
Negative yoy deferred tax while CSIQ stands at 100.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-0.78%
Both cut yoy SBC, with CSIQ at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-69.90%
Both reduce yoy usage, with CSIQ at -100.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
126.87%
AR growth well above CSIQ's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-158.13%
Negative yoy inventory while CSIQ is 100.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-213.14%
Both negative yoy AP, with CSIQ at -100.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
100.93%
Some yoy usage while CSIQ is negative at -100.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
127.29%
Some yoy increase while CSIQ is negative at -517.59%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-192.69%
Both yoy CFO lines are negative, with CSIQ at -100.00%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
45.69%
Lower CapEx growth vs. CSIQ's 100.00%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
100.00%
Acquisition spending well above CSIQ's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-861.93%
We reduce yoy other investing while CSIQ is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
68.83%
Investing outflow well above CSIQ's 100.00%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-374.75%
We cut debt repayment yoy while CSIQ is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-2400.26%
We cut yoy buybacks while CSIQ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.